Trial intelligence / Profile preview

Double Umbilical Cord Blood Transplantation for Malignant and Non-Malignant Disorders

NCT00801931Phase 2Terminated

Sponsor
Columbia University
Start
Sep 2007
Primary completion
May 2009
Modality
Hematopoietic Stem Cells
Countries
1
01

Overview

A Phase 2 trial of umbilical cord blood in leukemia, lymphoma, neuroblastoma, immunodeficiency, anemia, sponsored by Columbia University. Started Sep 2007; status: terminated.

02

Drugs

umbilical cord blood
03

Conditions

leukemialymphomaneuroblastomaimmunodeficiencyanemia

Beyond the preview

Go deeper on NCT00801931.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00801931.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call